{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T12:09:29Z","timestamp":1790683769834,"version":"4.1.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2022,10,5]],"date-time":"2022-10-05T00:00:00Z","timestamp":1664928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,10,5]],"date-time":"2022-10-05T00:00:00Z","timestamp":1664928000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100007657","name":"Univerza v Ljubljani","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007657","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["OBES SURG"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract\n<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Small intestinal bacterial overgrowth (SIBO) is defined as an excessive growth and\/or changed composition of bacteria in the small bowel. Obese patients are at increased risk of SIBO and related complications. The purpose of this study is to evaluate the incidence of SIBO after bariatric bypass procedures, connection between SIBO, symptoms, comorbidities, and liver pathology.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Patients underwent a hydrogen breath test with glucose substrate (25\u00a0g\/200\u00a0ml of water). The demographic, anthropometric data, comorbidities, and symptoms were analysed with a questionnaire. In 45 patients, the NAFLD Activity Score was evaluated in liver biopsies.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Glucose breath test was positive in 24\/56 (43%) of patients and was associated with higher frequency of defecation (<jats:italic>p<\/jats:italic>\u2009=\u20090.022), lactose intolerance (<jats:italic>p<\/jats:italic>\u2009=\u20090.047), scleroderma (<jats:italic>p<\/jats:italic>\u2009=\u20090.042), irritable bowel syndrome (<jats:italic>p<\/jats:italic>\u2009=\u20090.018), and diabetes (<jats:italic>p<\/jats:italic>\u2009=\u20090.002). Mean NAFLD Activity Score in SIBO patients (<jats:italic>n<\/jats:italic>\u2009=\u200918) was 3.33 and 3.00 in non-SIBO patients (<jats:italic>n<\/jats:italic>\u2009=\u200927). In SIBO-positive cohort of patients, a statistically important trend in difference between NAS and difference to range value anti-Xa 4\u00a0h after subtherapeutic dose application was calculated.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The incidence of SIBO after bariatric surgery bypass procedures is alarmingly high (43%). The results of our study conclude that diagnosis cannot be set based on specific symptom and SIBO is related to reduced response to the application of LMWH. Mandatory SIBO screening and appropriate treatment would affect the clinical outcome of the underlying disease, improve it significantly, and prevent the development of its complications.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Graphical abstract<\/jats:title>\n                \n              <\/jats:sec>","DOI":"10.1007\/s11695-022-06299-z","type":"journal-article","created":{"date-parts":[[2022,10,5]],"date-time":"2022-10-05T09:05:02Z","timestamp":1664960702000},"page":"4102-4109","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Small Intestinal Bacterial Overgrowth in Patients with Roux-en-Y Gastric Bypass and One-Anastomosis Gastric Bypass"],"prefix":"10.1007","volume":"32","author":[{"given":"Ur\u0161ka","family":"Novljan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4774-2541","authenticated-orcid":false,"given":"Tadeja","family":"Pintar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,5]]},"reference":[{"key":"6299_CR1","doi-asserted-by":"crossref","unstructured":"Tseng CH, Wu CY. The gut microbiome in obesity. Vol. 118, Journal of the Formosan Medical Association. Elsevier B.V.; 2019. p. S3\u20139.","DOI":"10.1016\/j.jfma.2018.07.009"},{"issue":"3","key":"6299_CR2","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s11695-016-2343-5","volume":"27","author":"JM Sabate","year":"2017","unstructured":"Sabate JM, Coupaye M, Ledoux S, Castel B, Msika S, Coffin B, et al. Consequences of small intestinal bacterial overgrowth in obese patients before and after bariatric surgery. Obes Surg. 2017;27(3):599\u2013605.","journal-title":"Obes Surg"},{"issue":"3","key":"6299_CR3","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1007\/s13105-015-0390-3","volume":"71","author":"MJ Villanueva-Mill\u00e1n","year":"2015","unstructured":"Villanueva-Mill\u00e1n MJ, P\u00e9rez-Matute P, Oteo JA. Gut microbiota: a key player in health and disease. A review focused on obesity. J Physiol Biochem. 2015;71(3):509\u201325.","journal-title":"J Physiol Biochem"},{"issue":"24","key":"6299_CR4","doi-asserted-by":"publisher","first-page":"2978","DOI":"10.3748\/wjg.v16.i24.2978","volume":"16","author":"J Bures","year":"2010","unstructured":"Bures J, Cyrany J, Kohoutova D, F\u00f6rstl M, Rejchrt S, Kvetina J, et al. Small intestinal bacterial overgrowth syndrome. World J Gastroenterol. 2010;16(24):2978\u201390.","journal-title":"World J Gastroenterol"},{"issue":"6","key":"6299_CR5","doi-asserted-by":"publisher","first-page":"2331","DOI":"10.1007\/s11695-020-04477-5","volume":"30","author":"T Mouillot","year":"2020","unstructured":"Mouillot T, Rhyman N, Gauthier C, Paris J, Lang AS, Lepers-Tassy S, et al. Study of small intestinal bacterial overgrowth in a cohort of patients with abdominal symptoms who underwent bariatric surgery. Obes Surg. 2020;30(6):2331\u20137.","journal-title":"Obes Surg"},{"key":"6299_CR6","doi-asserted-by":"publisher","unstructured":"Dolan RD, Baker J, Harer K, Lee A, Hasler W, Saad R, et al. Small intestinal bacterial overgrowth: clinical presentation in patients with Roux-en-Y gastric bypass. Available from: https:\/\/doi.org\/10.1007\/s11695-020-05032-y","DOI":"10.1007\/s11695-020-05032-y"},{"key":"6299_CR7","doi-asserted-by":"crossref","unstructured":"Bushyhead D, Quigley EMM. Small intestinal bacterial overgrowth pathophysiology and its implications for definition and management. Gastroenterology. 2022 Sep;","DOI":"10.1016\/j.gtc.2021.02.008"},{"issue":"4","key":"6299_CR8","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1007\/s11695-007-9398-2","volume":"18","author":"JM Sabat\u00e9","year":"2008","unstructured":"Sabat\u00e9 JM, Jou\u00ebt P, Harnois F, Mechler C, Msika S, Grossin M, et al. High prevalence of small intestinal bacterial overgrowth in patients with morbid obesity: a contributor to severe hepatic steatosis. Obes Surg. 2008;18(4):371\u20137.","journal-title":"Obes Surg"},{"key":"6299_CR9","unstructured":"\u010colak D, Pintar T, Cmok Ku\u010di\u010d A, Salobir J, Ga\u0161pirc B, Ga\u0161per\u0161i\u010d R. Periodontal and hepatic parameters in obese patients undergoing bariatric surgery. Oral Health Prev Dent [Internet]. 2022 Jun 28;20(1):295\u2013304. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/35866675"},{"issue":"12","key":"6299_CR10","doi-asserted-by":"publisher","first-page":"5583","DOI":"10.3390\/nu6125583","volume":"6","author":"SM Ferolla","year":"2014","unstructured":"Ferolla SM, Armiliato GNA, Couto CA, Ferrari TCA. The role of intestinal bacteria overgrowth in obesity-related nonalcoholic fatty liver disease. Nutrients. 2014;6(12):5583\u201399.","journal-title":"Nutrients"},{"key":"6299_CR11","doi-asserted-by":"crossref","unstructured":"Langenberg van D, Rky C. 32 Outcomes of a drug shortage requiring switching in patients with ulcerative colitis. World Journal of Gastrointestinal Pathophysiology World J Gastrointest Pathophysiol [Internet]. 2020;11(2):20\u201342. Available from: https:\/\/www.wjgnet.com\/bpg\/gerinfo\/240","DOI":"10.4291\/wjgp.v11.i2.32"},{"key":"6299_CR12","doi-asserted-by":"crossref","unstructured":"Augustyn M, Grys I, Kukla M. Small intestinal bacterial overgrowth and nonalcoholic fatty liver disease. Vol. 5, Clinical and Experimental Hepatology. Termedia Publishing House Ltd.; 2019. p. 1\u201310.","DOI":"10.5114\/ceh.2019.83151"},{"key":"6299_CR13","doi-asserted-by":"publisher","unstructured":"Ramori Farinha Wagner N, Rizzon Zaparolli Ramos M, de Oliveira Carlos L, Rosa Ramos da Cruz M, Augusto Taconeli C, Jos\u00e9 Branco Filho A, et al. Effects of probiotics supplementation on gastrointestinal symptoms and SIBO after Roux-en-Y gastric bypass: a prospective, randomized, double-blind, placebo-controlled trial. Available from: https:\/\/doi.org\/10.1007\/s11695-020-04900-x","DOI":"10.1007\/s11695-020-04900-x"},{"key":"6299_CR14","doi-asserted-by":"crossref","unstructured":"Gomaa EZ. Human gut microbiota\/microbiome in health and diseases: a review. Vol. 113, Antonie van Leeuwenhoek, International Journal of General and Molecular Microbiology. Springer Science and Business Media Deutschland GmbH; 2020. p. 2019\u201340.","DOI":"10.1007\/s10482-020-01474-7"},{"key":"6299_CR15","doi-asserted-by":"crossref","unstructured":"Dixit K, Chaudhari D, Dhotre D, Shouche Y, Saroj S. Restoration of dysbiotic human gut microbiome for homeostasis. Vol. 278, Life Sciences. Elsevier Inc.; 2021.","DOI":"10.1016\/j.lfs.2021.119622"},{"key":"6299_CR16","doi-asserted-by":"crossref","unstructured":"Bakhshimoghaddam F, Alizadeh M. Contribution of gut microbiota to nonalcoholic fatty liver disease: pathways of mechanisms. Vol. 44, Clinical Nutrition ESPEN. Elsevier Ltd; 2021. p. 61\u20138.","DOI":"10.1016\/j.clnesp.2021.05.012"},{"issue":"7122","key":"6299_CR17","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1038\/nature05414","volume":"444","author":"PJ Turnbaugh","year":"2006","unstructured":"Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature. 2006;444(7122):1027\u201331.","journal-title":"Nature"},{"key":"6299_CR18","doi-asserted-by":"crossref","unstructured":"Shah A, Morrison M, Burger D, Martin N, Rich J, Jones M, et al. Systematic review with meta-analysis: the prevalence of small intestinal bacterial overgrowth in inflammatory bowel disease. Vol. 49, Alimentary Pharmacology and Therapeutics. Blackwell Publishing Ltd; 2019. p. 624\u201335.","DOI":"10.1111\/apt.15133"},{"key":"6299_CR19","doi-asserted-by":"crossref","unstructured":"Quigley EMM. The spectrum of small intestinal bacterial overgrowth (SIBO). Vol. 21, Current Gastroenterology Reports. Current Medicine Group LLC 1; 2019.","DOI":"10.1007\/s11894-019-0671-z"},{"key":"6299_CR20","doi-asserted-by":"crossref","unstructured":"Miazga A, Osi\u0144ski M, Cichy W, Zaba R. Current views on the etiopathogenesis, clinical manifestation, diagnostics, treatment and correlation with other nosological entities of SIBO. Vol. 60, Advances in Medical Sciences. Medical University of Bialystok; 2015. p. 118\u201324.","DOI":"10.1016\/j.advms.2014.09.001"},{"issue":"3","key":"6299_CR21","doi-asserted-by":"publisher","first-page":"277","DOI":"10.3109\/00365521.2015.1086020","volume":"51","author":"E Ierardi","year":"2016","unstructured":"Ierardi E, Losurdo G, Sorrentino C, Giorgio F, Rossi G, Marinaro A, et al. Macronutrient intakes in obese subjects with or without small intestinal bacterial overgrowth: an alimentary survey. Scand J Gastroenterol. 2016;51(3):277\u201380.","journal-title":"Scand J Gastroenterol"},{"issue":"1","key":"6299_CR22","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s10620-010-1239-9","volume":"56","author":"AM Madrid","year":"2011","unstructured":"Madrid AM, Poniachik J, Quera R, Defilippi C. Small intestinal clustered contractions and bacterial overgrowth: a frequent finding in obese patients. Dig Dis Sci. 2011;56(1):155\u201360.","journal-title":"Dig Dis Sci"},{"key":"6299_CR23","doi-asserted-by":"crossref","unstructured":"Gupta A, Osadchiy V, Mayer EA. Brain\u2013gut\u2013microbiome interactions in obesity and food addiction. Vol. 17, Nature Reviews Gastroenterology and Hepatology. Nature Research; 2020. p. 655\u201372.","DOI":"10.1038\/s41575-020-0341-5"},{"issue":"2","key":"6299_CR24","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/s11695-018-3540-1","volume":"29","author":"ELS de Bastos","year":"2019","unstructured":"de Bastos ELS, Liberatore AMA, Tedesco RC, Koh IHJ. Gut microbiota imbalance can be associated with non-malabsorptive small bowel shortening regardless of blind loop. Obes Surg. 2019;29(2):369\u201375.","journal-title":"Obes Surg"},{"key":"6299_CR25","doi-asserted-by":"crossref","unstructured":"Takakura W, Pimentel M. Small intestinal bacterial overgrowth and irritable bowel syndrome \u2013 an update. Vol. 11, Frontiers in Psychiatry. Frontiers Media S.A.; 2020.","DOI":"10.3389\/fpsyt.2020.00664"},{"key":"6299_CR26","doi-asserted-by":"publisher","unstructured":"Ghafoor A, Karunaratne T, Rao SSC. Bacterial overgrowth and lactose intolerance: how to best assess. Curr Opin Clin Nutr Metab Care [Internet]. 2022 Sep;25(5):334\u201340. Available from: https:\/\/journals.lww.com\/https:\/\/doi.org\/10.1097\/MCO.0000000000000861","DOI":"10.1097\/MCO.0000000000000861"},{"key":"6299_CR27","doi-asserted-by":"crossref","unstructured":"Polkowska-Pruszy\u0144ska B, Gerkowicz A, Rawicz-Pruszy\u0144ski K, Krasowska D. The role of fecal calprotectin in patients with systemic sclerosis and small intestinal bacterial overgrowth (SIBO). Diagnostics. 2020 Aug 1;10(8).","DOI":"10.3390\/diagnostics10080587"},{"issue":"1","key":"6299_CR28","doi-asserted-by":"publisher","first-page":"58","DOI":"10.3945\/ajcn.110.010132","volume":"94","author":"R Jumpertz","year":"2011","unstructured":"Jumpertz R, Le DS, Turnbaugh PJ, Trinidad C, Bogardus C, Gordon JI, et al. Energy-balance studies reveal associations between gut microbes, caloric load, and nutrient absorption in humans. Am J Clin Nutr. 2011;94(1):58\u201365.","journal-title":"Am J Clin Nutr"},{"key":"6299_CR29","doi-asserted-by":"crossref","unstructured":"Weiss GA, Hennet T. Mechanisms and consequences of intestinal dysbiosis. Vol. 74, Cellular and Molecular Life Sciences. Birkhauser Verlag AG; 2017. p. 2959\u201377.","DOI":"10.1007\/s00018-017-2509-x"},{"key":"6299_CR30","doi-asserted-by":"crossref","unstructured":"Albaugh VL, Banan B, Ajouz H, Abumrad NN, Flynn CR. Bile acids and bariatric surgery. Vol. 56, Molecular Aspects of Medicine. Elsevier Ltd; 2017. p. 75\u201389.","DOI":"10.1016\/j.mam.2017.04.001"},{"issue":"4","key":"6299_CR31","first-page":"294","volume":"111","author":"F Domper-Bardaj\u00ed","year":"2019","unstructured":"Domper-Bardaj\u00ed F, Gil-Rendo A, Illescas-Fern\u00e1ndez-Bermejo S, Pat\u00f3n-Arenas R, Hern\u00e1ndez-Alb\u00fajar A, Mart\u00edn-D\u00e1vila F, et al. An assessment of bacterial overgrowth and translocation in the non-alcoholic fatty liver of patients with morbid obesity. Rev Esp Enferm Dig. 2019;111(4):294\u20139.","journal-title":"Rev Esp Enferm Dig"},{"key":"6299_CR32","doi-asserted-by":"crossref","unstructured":"Mikolasevic I, Delija B, Mijic A, Stevanovic T, Skenderevic N, Sosa I, et al. Small intestinal bacterial overgrowth and non-alcoholic fatty liver disease diagnosed by transient elastography and liver biopsy. Int J Clin Pract. 2021 Apr 1;75(4).","DOI":"10.1111\/ijcp.13947"},{"issue":"1","key":"6299_CR33","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1111\/jgh.13058","volume":"31","author":"S Kapil","year":"2016","unstructured":"Kapil S, Duseja A, Sharma BK, Singla B, Chakraborti A, Das A, et al. Small intestinal bacterial overgrowth and toll-like receptor signaling in patients with non-alcoholic fatty liver disease. Journal of Gastroenterology and Hepatology (Australia). 2016;31(1):213\u201321.","journal-title":"Journal of Gastroenterology and Hepatology (Australia)"}],"container-title":["Obesity Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11695-022-06299-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11695-022-06299-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11695-022-06299-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,18]],"date-time":"2022-11-18T02:19:26Z","timestamp":1668737966000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11695-022-06299-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,5]]},"references-count":33,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["6299"],"URL":"https:\/\/doi.org\/10.1007\/s11695-022-06299-z","relation":{},"ISSN":["0960-8923","1708-0428"],"issn-type":[{"value":"0960-8923","type":"print"},{"value":"1708-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,5]]},"assertion":[{"value":"29 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that informed consent was obtained from all individual participants included in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}},{"value":"All procedures performed in study involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statement of Human Rights"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}